Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New IKK inhibitors in early development at Roche

June 5, 2003

Novel MMP, TACE and/or aggrecanase inhibitors and their use reported by BMS scientists

June 2, 2003

Imidazolinone-based p38 kinase inhibitors in early development at Tanabe Seiyaku

June 2, 2003

Five related series of COX-2 inhibitors reported by Pfizer in recent patents

May 28, 2003

Boehringer Ingelheim patent covers cathepsin inhibitors for autoimmune diseases and other uses

May 28, 2003

Wyeth and Takeda sign new partnership agreements

May 26, 2003

EMEA hands down positive opinion on Humira

May 26, 2003

Etanercept does not increase the rate of malignancies in rheumatoid arthritis

May 23, 2003

First anti-TNF agent approved for ankylosing spondylitis in E.U.

May 22, 2003

Bextra approved in Europe

May 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...